SAREUM HOLDINGS PLC
Clinical-stage company developing kinase inhibitors for autoimmune diseases and cancer.
SAR | IL
Overview
Corporate Details
- ISIN(s):
- GB00BMC3RJ87
- LEI:
- 213800PKERN2DY8FFM72
- Country:
- United Kingdom
- Address:
- UNIT 2A, CB22 3FX CAMBRIDGE
- Website:
- https://www.sareum.com/
- Sector:
- Manufacturing
Description
Sareum Holdings PLC is a clinical-stage small molecule company that discovers and develops next-generation kinase inhibitors for the treatment of autoimmune diseases and cancer. The company's research is primarily focused on the TYK/JAK kinase cell signalling family, with a specific emphasis on developing dual inhibitors of TYK2 and JAK1. This approach is pursued for its potential to offer superior efficacy compared to agents that target only one of these kinases. Its development pipeline includes SDC-1801, a potential oral therapy for autoimmune diseases, as well as other programs targeting cancer and viral infections.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-03-15 08:00 |
New Patent Allowance
|
English | 11.8 KB | ||
| 2024-03-12 14:30 |
Notice of Interim Results and Trading Update
|
English | 13.4 KB | ||
| 2024-02-15 08:00 |
Update on SDC-1801 Clinical Trial Progress
|
English | 16.4 KB | ||
| 2024-01-02 08:00 |
Development and commercialisation licence SRA737
|
English | 15.7 KB | ||
| 2023-12-14 16:35 |
Results of AGM
|
English | 24.6 KB | ||
| 2023-12-14 08:00 |
Annual General Meeting Statement
|
English | 16.9 KB | ||
| 2023-11-23 08:00 |
Drawdown of Equity Prepayment Facility
|
English | 10.5 KB | ||
| 2023-11-21 08:00 |
Notice of AGM, Annual Report and Accounts
|
English | 10.6 KB | ||
| 2023-11-09 08:00 |
Initiation of food effects study for SDC-1801
|
English | 14.5 KB | ||
| 2023-11-08 16:03 |
Director Dealings
|
English | 35.3 KB | ||
| 2023-11-03 08:05 |
Sareum enhances SDC-1801 patent protection
|
English | 13.1 KB | ||
| 2023-11-02 15:48 |
Exercise of Share Options and Director Dealings
|
English | 37.1 KB | ||
| 2023-10-09 08:00 |
Final Results for the Year Ended 30 June 2023
|
English | 252.3 KB | ||
| 2023-10-03 08:00 |
Notice of Results and Investor Presentation
|
English | 10.8 KB | ||
| 2023-09-06 08:00 |
Director's Dealing
|
English | 28.4 KB |
Automate Your Workflow. Get a real-time feed of all SAREUM HOLDINGS PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for SAREUM HOLDINGS PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for SAREUM HOLDINGS PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
